Autonomix medical, inc. announces inducement grant under nasdaq listing rule 5635(c)(4)

The woodlands, tx, march 21, 2025 (globe newswire) -- autonomix medical, inc. (nasdaq: amix) (“autonomix” or the “company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced that the compensation committee of autonomix's board of directors approved the grant of an inducement stock option on march 17, 2025 to purchase 7,500 shares of the company's common stock, to a new non-executive employee pursuant to the nasdaq rule 5635(c)(4) inducement grant exception, as a component of the individual's employment compensation and was granted as an inducement material to their start of employment with the company.
AMIX Ratings Summary
AMIX Quant Ranking